OPA1 and non-small cell lung carcinoma: In the current study, we identify lipogenesishi as an initiator for SPDEFhi, high OPA1, and mitochondrial-fusionhi in NSCLC CSCs, providing a mechanism underlying the crucial involvement of lipid metabolism in CSC biology.